Acquisition of Triamcinolone 40 mg/ml Inj Susp Intra-articular 1ml

This tender is for the procurement of Triamcinolone 40 mg/ml injectable suspension for intra-articular use, supplied in 1ml vials. Triamcinolone acetonide is a corticosteroid commonly used to treat inflammatory conditions affecting joints, such as arthritis. The procurement aims to ensure a consistent supply of this essential medication for healthcare facilities. Interested suppliers must provide products that meet stringent pharmaceutical quality standards and regulatory requirements. The tender documents will detail the required quantities, packaging specifications, delivery schedules, and any specific storage or handling instructions. Bidders are expected to demonstrate their capacity to supply high-quality pharmaceutical products reliably. The evaluation criteria will likely focus on product quality, compliance with specifications, price, and the supplier's ability to meet delivery timelines. This acquisition is crucial for patient treatment and management of joint-related inflammatory diseases.

This is a supplies contract in the health and medical services, trade and industry and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 3,591.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.